Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
批准号:
10358434
负责人:
Sarah E Clark
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-01 至 2025-01-31
关键词:
6 year oldAddressAnimal ModelAnti-Inflammatory AgentsAntibiotic ResistanceAntibioticsBacterial ProteinsChildClinicalClinical ManagementCorynebacteriumDataDefectDevelopmentDiagnosisDiseaseDouble-Stranded RNAFlow CytometryGoalsGrowthHistologyHospitalsIFNAR1 geneIL8RB geneImageImmuneImmunotherapyIn VitroInfectionInflammationInflammatoryInjectionsInnate Immune ResponseIntegration Host FactorsInterferon Type IInterferon-alphaInterferonsInterleukin-10Interleukin-8B ReceptorKnockout MiceKnowledgeLungMeasuresMediatingModelingMusMyeloid CellsNasopharynxNeutrophil InfiltrationOtitis MediaPathogenesisPathway interactionsPneumococcal InfectionsPopulationPredispositionProbioticsProcessProductionProteinsRecurrenceReportingResistanceRiskRoleSignal TransductionSiteSourceStimulusStreptococcus pneumoniaeStreptococcus pneumoniae plY proteinTissuesUpper respiratory tractVaccinesViralVirulenceVirus ReplicationVisitWild Type Mouseage groupanalogbasecell typechemokine receptorchildhood hearing lossclinically significantco-infectioncytokineeconomic impactexperimental studyhearing impairmenthost microbiomeimmune activationimprovedinfection burdenmicrobiomemiddle earmouse modelneutrophilnext generation sequencingnovelnovel therapeutic interventionpathogenpathogenic bacteriapathogenic viruspreventprotein expressionrecruitrecurrent infectionrespiratoryresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This proposal addresses the clinically significant issue of bacterial otitis media (OM), a major source of hospital
visits and preventable hearing loss in young children and the most common diagnosis for antibiotic
prescriptions in this age group. Streptococcus pneumoniae is one of the two most common causes of bacterial
OM, which results from bacterial invasion from the nasopharynx to the middle ear. Despite widespread vaccine
use, S. pneumoniae remains a significant OM pathogen, indicating the need for new therapeutic approaches.
However, large knowledge gaps remain regarding the host factors which contribute to bacterial OM
pathogenesis. To address these knowledge gaps, we developed a new mouse model of S. pneumoniae
invasion to the middle ear. This model is based on the clinical observation that viral co-infection increases OM
risk in children, and in mice promotes S. pneumoniae invasion. We find that serial administration of the viral
dsRNA analog poly(I:C) is sufficient to promote S. pneumoniae invasion to the middle ear. Poly(I:C) induces
the production of type I interferons (IFNs), which contribute to S. pneumoniae survival in other tissues. In the
first Aim, we address the hypothesis that type I IFNs enhance S. pneumoniae survival in the middle ear. Type I
IFNs can induce production of the anti-inflammatory cytokine IL-10, which we recently demonstrated
suppresses protection against S. pneumoniae infection in the lung. Here, we investigate whether IL-10
signaling in poly(I:C) treated mice enhances S. pneumoniae survival following middle ear invasion, as well as
the impact of IL-10 on middle ear inflammation. Together, these experiments will determine whether type I
IFNs contribute to S. pneumoniae OM pathogenesis. In the second Aim, we investigate the importance of the
host microbiome. Children treated with antibiotics are susceptible to recurrent bacterial OM, and pathogens
including S. pneumoniae are more resistant to antibiotics than many commensal (non-pathogenic) species. In
preliminary data, we find that antibiotic treated mice have increased S. pneumoniae invasion and reduced
neutrophil recruitment to the middle ear. We investigate the importance of microbiome-dependent neutrophil
recruitment for early clearance of S. pneumoniae following middle ear invasion. In the upper airway, the
prevalent commensal Corynebacterium has been identified by next-generation sequencing as negatively
correlated with OM in children, indicating a potentially protective role. Here, we determine whether
Corynebacterium improves protection against S. pneumoniae OM in our mouse model as a first step toward
developing new probiotic-based approaches for OM in children. The long-term goal of these studies is to
develop novel immunotherapy and/or probiotic strategies to improve the burden of OM disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Airway Prevotella enhance innate immune-mediated protection against lung infection
-
批准号:10561450
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2023
-
负责人:Sarah E Clark
-
依托单位:
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
-
批准号:10551220
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2022
-
负责人:Sarah E Clark
-
依托单位:
Bacterial-driven immune suppression in the lung
-
批准号:10475452
-
项目类别:
-
资助金额:$4.04万
-
财政年份:2019
-
负责人:Sarah E Clark
-
依托单位:
Natural killer cell-derived IL-10 and immunity to Listeria
-
批准号:8975083
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2014
-
负责人:Sarah E Clark
-
依托单位:
Natural killer cell-derived IL-10 and immunity to Listeria
-
批准号:8783266
-
项目类别:
-
资助金额:$5.15万
-
财政年份:2014
-
负责人:Sarah E Clark
-
依托单位:
海外基金